Gynecologic Oncology Tumor Board (MSH) 2026 - 4/7/2026

Tuesday, April 7, 2026, 7:00 AM - 8:00 AM, Online, New York, NY


Gynecologic Oncology Tumor Board is an educational regularly scheduled conference that provides a forum to discuss patients with gynecologic malignancies and how they are diagnosed and treated. We want to expand the fund of knowledge of residents, fellows, attendings as it pertains to Gynecologic cancers. We review radiographic and pathology findings. This conference also provides the opportunity to present and discuss protocol eligible patients which is crucial to the ongoing effort by the Icahn School of Medicine to expand its cancer research services.

1. To ensure the practice of evidence- and guideline-based care for gynecologic oncology patients.
2. To assess patients for protocol eligibility.
3. To improve patient safety and outcomes by discussing morbidity occurrences, their management and how to ultimately minimize these events from occurring.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (1.00 hours), ABS CC (1.00 hours), Non-Physician Attendance (1.00 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

Icahn School of Medicine at Mount Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
4/7/2026 7:00:00 AM	Gynecologic Oncology Tumor Board (MSH) 2026 - 4/7/2026 4/7/2026 7:00:00 AM 4/7/2026 8:00:00 AM 15 Online False MM/DD/YYYY	Gynecologic Oncology Tumor Board (MSH) 2026 - 4/7/2026 Gynecologic Oncology Tumor Board is an educational regularly scheduled conference that provides a forum to discuss patients with gynecologic malignancies and how they are diagnosed and treated. We want to expand the fund of knowledge of residents, fellows, attendings as it pertains to Gynecologic cancers. We review radiographic and pathology findings. This conference also provides the opportunity to present and discuss protocol eligible patients which is crucial to the ongoing effort by the Icahn School of Medicine to expand its cancer research services. Location: Online Specialties: Academic/Research, Gynecology, Nurse Practitioner, Ob/Gyn, Oncology, Pathology, Physician Assistant, Radiation Oncology